Back to 
BNP PARIBAS FINANCIAL MARKETS
BNP PARIBAS FINANCIAL MARKETS
DCPHShowing 0 of 23 quarters
Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in DECIPHERA PHARMACEUTICALS IN
As of its Q1 2024 13F, BNP Paribas Financial Markets held 36,480 shares of DCPH (Deciphera Pharmaceuticals in), worth $573,830. BNP Paribas Financial Markets' 13F filings listed DCPH from Q4 2018 to Q1 2024, 22 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DCPH: FRANKLIN TEMPLETON INC